Investing
Politics
Stock
Economy
Editor’s Pick

Home Economy RAD 202 receives approval to start Phase 1 therapeutic trial

RAD 202 receives approval to start Phase 1 therapeutic trial

by GoldMedalInvestments December 20, 2024

December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

next post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

You may also like

Top 5 Canadian Mining Stocks This Week: Omineca...

December 21, 2024

Opawica Announces the Closing of Non-Brokered Private Placement

December 21, 2024

Silver Price Forecast: Top Trends That Will Affect...

December 21, 2024

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024

Skyharbour Announces Closing of Private Placement for Gross...

December 21, 2024

5 Best-performing Canadian Nickel Stocks of 2024

December 20, 2024

Westgold Shares Scoping Study for Expansion of Fortnum...

December 20, 2024

PRISM MarketView Features Q&A with President and CEO...

December 20, 2024

Forum Comments on Share Price

December 20, 2024

Jindalee Lithium

December 19, 2024

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Categories

Economy (78)
Editor's Pick (41)

About us
Contacts
Privacy Policy
Terms and Conditions
Email Whitelisting

Copyright © 2024 GoldMedalInvestments.com All Rights Reserved.

Investing
Politics
Stock
Economy
Editor’s Pick